RxDoctor Payments Data

David Lubeck, MD

Ophthalmology · Homewood, ILNPI 1245291921

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $416,323 of the $575,093 with a category attached, or 72.4%. 15 manufacturers reported payments, led by Alcon at 42.0% of the total. Reporting peaked in 2019 at $219,936 and has fallen 89.4% since, to $23,416 in 2025. Among ophthalmology clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$575,093in general payments, 2019–2025

Across 296 payments — averaging $1942.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon$241K
  • Ellexiscience$102K
  • Lumibird Medical Inc.$90K
  • Nova Eye, Inc.$85K
  • Alcon Research LLC$49K
  • Beaver-visitec International, Inc.$4K
  • plus $4K from 9 others
$248,114in research payments, 2019–2025

Across 94 payments — averaging $2639.51 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Beaver-visitec International, Inc.$114K
  • Glaukos Corporation$73K
  • Kowa Research Institute, Inc.$54K
  • Alcon Research LLC$7K

What the payments were for

  • Consulting fees$416,32372%
  • Speaking & faculty fees$98,89317%
  • Travel & lodging$51,3099%
  • Food & beverage$7,8191%
  • Education$3000%
  • Gifts$1670%
  • Entertainment$2820%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$575,093 in reported general payments places this provider in the 95th percentile of 773 ophthalmology providers in Illinois.

See all ophthalmology providers in Illinois

Medicare billing

Part B allowed, 2024
$583,735
Medicare patients
662
Services billed
2,497

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate570$30,336
Ketorolac Tromethamine385$9,976
LotemaxLoteprednol Etabonate14$5,336
Ciprofloxacin Hcl427$4,882
RhopressaNetarsudil Mesylate12$3,789
Fluorometholone26$2,558
Loteprednol Etabonate15$2,346
MoxifloxacinMoxifloxacin Hcl76$1,687
Difluprednate11$1,280
Atropine Sulfate26$1,204
Doxycycline Hyclate12$983
ValacyclovirValacyclovir Hcl17$663
ErythromycinErythromycin Base38$628
Latanoprost57$551
Brimonidine Tartrate42$457

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Homewood

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →